Zanamivir as prophylaxis
Last reviewed 01/2018
A double-blind placebo controlled study of inhaled Zanamivir for the treatment and prevention of influenza in families had a 79% efficacy in preventing secondary cases when drug was given for 10 days to all exposed family members.
Reference:
- 1) Hayden FG et al (2000). Inhaled Zanamivir for the prevention of influenza in families. NEJM, 343(18), 1282-1289.